Home / Immunoglobulins, Normal Human, for Intravascular Adm. / Sweden
SE ATC J06BA02 · updated 2 Nov 2026
Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Sweden
Is there an Immunoglobulins, Normal Human, for Intravascular Adm. shortage in Sweden?
Yes. As of 2 Nov 2026, 4 Immunoglobulins, Normal Human, for Intravascular Adm. products are reported short in Sweden, the first since 30 Mar 2023. The company estimate for the return is 20 Nov 2026 (latest 30 Jun 2027). Main reason: not stated.
Also short in Italy, Spain, Austria, Belgium, Switzerland. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Octagam 100 mg/ml Flaska, 1 x 300 ml | Octapharma AB | 30 Mar 2023 | 30 Jun 2027 | Not stated |
| SE | Octagam 100 mg/ml Injektionsflaska, 1 x 20 ml | Octapharma AB | 9 Mar 2026 | 30 Jun 2027 | Not stated |
| SE | Octagam 100 mg/ml Flaska, 1 x 50 ml | Octapharma AB | 16 Sep 2026 | 31 Dec 2026 | Not stated |
| SE | Gamunex 100 mg/ml Flaska, 1 x 400 ml | Grifols Deutschland GmbH | 23 Oct 2026 | 20 Nov 2026 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.